The clinical need in the development of non-invasive methods for liver fibrosis assessment has emerged. At 3.0T, human in-vivo studies have demonstrated DCE-MRI using Exchange dual-input and dual-compartment pharmacokinetic model has potential to detect and assess the vascular permeability modification of liver fibrosis. DCE-MRI pharmacokinetic quantitative parameters including Ktrans, Ve and Vp can be used for diagnosing and staging liver fibrosis. Ktrans is the best index and predictor for discriminating normal livers from fibrotic livers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords